• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; STENT, CAROTID Back to Search Results
Catalog Number PC0840RXC
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/11/2019
Event Type  malfunction  
Manufacturer Narrative
Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, a precise pro (rx us carotid syst) self-expanding stent (ses) was deployed partially before putting it into the body.There was no reported patient injury.The device was stored as per labeling.The device was opened in sterile field.The precise ses stent was not used in patient.The device was stored and handled per the instructions for use (ifu).The device was not being used for treatment of a chronic total occlusion.The stent partially deployed when removing.The precise stent pre-maturely deployed.The stent deployed ¼ of it.There was no attempt made to re-capture the stent.The stent was never implanted.There are no pictures available of the cordis devices used.The device will be returned for analysis.
 
Manufacturer Narrative
A review of the manufacturing documentation associated with lot (17836347) presented no issues during the manufacturing process that can be related to the reported event.Additional information is pending and will be submitted within 30 days upon receipt.
 
Manufacturer Narrative
A precise pro (rx us carotid system) self-expanding stent (ses) was deployed partially before putting it into the body.There was no reported patient injury.The device was stored as per labeling.The device was opened in sterile field.The precise ses stent was not used in patient.The device was stored and handled per the instructions for use (ifu).The device was not being used for treatment of a chronic total occlusion.The stent partially deployed when removing.The precise stent pre-maturely deployed.The stent deployed ¼ of it.There was no attempt made to re-capture the stent.The stent was never implanted.The device was returned for analysis.One non-sterile precise pro rx us carotid stent delivery system was received for analysis inside a plastic bag.No original packaging was returned.Per visual analysis, the valve of the unit was received partially locked/ closed.The stent of the unit was received already deployed and stent was not returned.A kink was observed on the catheter shaft at 8.1 cm from the strain relief.Also, catheter¿s shaft was observed accordioned at 8.5 cm from the strain relief.No other anomalies were observed.Per dimensional analysis the usable length of unit couldn¿t be properly measured due to the kinked and accordioned condition of the unit.Per functional analysis a deployment test couldn¿t be performed since stent was already deployed.A product history record (phr) review of lot 17836347 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿stent delivery system (sds)-ses - deployment difficulty - premature/during prep¿ was confirmed through analysis of the returned device as the stent had been deployed and was not returned for analysis.The exact cause of the event could not be determined during analysis.Based on the information available for review, procedural and handling factors may have contributed to the event as evidenced by a kink and an accordioned condition noted on the shaft during analysis.According to the instructions for use, which is not intended as a mitigation of risk, ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.¿ neither the phr review nor the product analysis suggests that the event experienced by the customer could be related to the manufacturing process; therefore, no corrective/preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX US CAROTID SYST
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th ave
miami lakes FL 33014
MDR Report Key8861886
MDR Text Key203007451
Report Number9616099-2019-03118
Device Sequence Number1
Product Code NIM
UDI-Device Identifier20705032036495
UDI-Public20705032036495
Combination Product (y/n)N
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 09/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2020
Device Catalogue NumberPC0840RXC
Device Lot Number17836347
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 07/11/2019
Initial Date FDA Received08/05/2019
Supplement Dates Manufacturer Received08/08/2019
09/11/2019
Supplement Dates FDA Received08/30/2019
09/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-